Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Study Details
Study Description
Brief Summary
The purpose of this study is to determine whether Motivating Youth to Reduce Infections, Disconnections, and Emotion dysregulation (MY-RIDE) decreases substance use , to determine whether MY-RIDE increases human immunodeficiency virus (HIV) prevention strategies and to evaluate MY-RIDE effects on willingness to take Pre-Exposure Prophylaxis (PrEP), stress, substance use urge, and use of mental health and substance use services when compared to attention control youth
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
N/A |
Study Design
Arms and Interventions
Arm | Intervention/Treatment |
---|---|
Experimental: MY-RIDE group
|
Behavioral: MY-RIDE group
MY-RIDE has three main components: 1) One nurse-led face-to-face session; 2) three months of Ecological Momentary Assessments (EMA) with personalized messaging delivered by phone in real-time in response to one's current risk; and 3) access to on-demand healthcare/PrEP navigation and referrals.
|
Active Comparator: Attention-control group
|
Behavioral: Attention-control group
Participants will receive a one-hour general health promotion session from a nurse and be issued a phone that will deploy the EMA on the same schedule as the intervention arm. They will also receive usual care from the clinics, drop-in center, and shelter recruitment sites. Usual care includes accessing social workers and case managers for immediate housing, food, and clothing needs and assistance in navigating the local Continuum of Care system to access social services.
|
Outcome Measures
Primary Outcome Measures
- Change in substance use [baseline, 3, 6, and 12 months]
Secondary Outcome Measures
- Change in condom use [baseline, 3, 6, and 12 months]
- Change in PrEP uptake as assessed by the self reported tool [baseline, 3, 6, and 12 months]
PrEP uptake is defined as the self initiation of HIV prevention medication
- Change in sexually transmitted infections (STIs) [baseline, 3, 6, and 12 months]
This will be assessed by a blood test to detect biomarkers for HIV and Syphilis, and urine test for Gonorrhea and Chlamydia
Eligibility Criteria
Criteria
Inclusion Criteria:
-
have engaged in substance use (alcohol or illicit drugs)
-
speak English
-
are experiencing homelessness
-
engaged in sexual activity in the last 6 months or plan to in the next month
-
are not planning to move out of the metro area during the 12-month study period.
Exclusion Criteria:
- Youth Experiencing Homelessness (YEH) who have low literacy based on the Rapid Estimate of Adult Literacy in Medicine-Short Form (scores < 4)
Contacts and Locations
Locations
Site | City | State | Country | Postal Code | |
---|---|---|---|---|---|
1 | The University of Texas Health Science Center at Houston | Houston | Texas | United States | 77030 |
Sponsors and Collaborators
- The University of Texas Health Science Center, Houston
- National Institute of Nursing Research (NINR)
Investigators
- Principal Investigator: Diane M Santa Maria, DrPH, MSN, RN, PHNA-BC, FSAHM,, The University of Texas Health Science Center, Houston
Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- HSC-SN-23-0360